Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuqi Chen

Showing results (311-320 of 321) with videos related to

Pageof 33
Sort By:
International Journal of Biological Sciences|March 26, 2019
The LIM-Only Protein FHL2 is involved in Autophagy to Regulate the Development of Skeletal Muscle CellZihao Liu, Shunshun Han, Yan Wang, et al.
British Journal of Cancer|September 5, 2025
Unraveling cellular dynamic changes in tumor evolution induced by long-term low dose-rate radiationWanshi Li, Weiwei Pei, Yiwei Wang, et al.
Frontiers in Immunology|January 8, 2026
Xuebijing injection mitigates instant blood-mediated inflammatory reaction and enhances intrahepatic islet transplantation via target NF-κB pathwayYixiang Zhan, Yingbo Wang, Boya Zhang, et al.
Gut|August 8, 2023
Novel tripeptide RKH derived from <i>Akkermansia muciniphila</i> protects against lethal sepsisShihao Xie, Jiaxin Li, Fengyuan Lyu, et al.
Hepatology (Baltimore, Md.)|March 21, 2025
Neutrophil serine proteases NE and PR3 controlled by the miR-223/STAT3 axis potentiate MASH and liver fibrosisPengfei Zhang, Dongyang Liu, Lihong Wu, et al.
Hematology (Amsterdam, Netherlands)|August 24, 2022
Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational studyHongsheng Zhou, Qingsong Yin, Jie Jin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2023
Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsisJiaxin Li, Yuqi Chen, Rui Li, et al.
Leukemia & Lymphoma|May 3, 2022
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCLDeborah A Katz, Joan D Morris, Michael P Chu, et al.
The Journal of Infectious Diseases|March 15, 2026
Unnoticed Entry, Noticed Transmission: Epidemiological Insights into China's First clade Ib MPXV clusterXin Ye, Peng He, Baiyun Yu, et al.
American Journal of Hematology|February 6, 2024
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemiaElias Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, et al.
Pageof 33

Showing results (311-320 of 321) with videos related to

Sort By:
Pageof 33
International Journal of Biological Sciences|March 26, 2019
The LIM-Only Protein FHL2 is involved in Autophagy to Regulate the Development of Skeletal Muscle CellZihao Liu, Shunshun Han, Yan Wang, et al.
British Journal of Cancer|September 5, 2025
Unraveling cellular dynamic changes in tumor evolution induced by long-term low dose-rate radiationWanshi Li, Weiwei Pei, Yiwei Wang, et al.
Frontiers in Immunology|January 8, 2026
Xuebijing injection mitigates instant blood-mediated inflammatory reaction and enhances intrahepatic islet transplantation via target NF-κB pathwayYixiang Zhan, Yingbo Wang, Boya Zhang, et al.
Gut|August 8, 2023
Novel tripeptide RKH derived from <i>Akkermansia muciniphila</i> protects against lethal sepsisShihao Xie, Jiaxin Li, Fengyuan Lyu, et al.
Hepatology (Baltimore, Md.)|March 21, 2025
Neutrophil serine proteases NE and PR3 controlled by the miR-223/STAT3 axis potentiate MASH and liver fibrosisPengfei Zhang, Dongyang Liu, Lihong Wu, et al.
Hematology (Amsterdam, Netherlands)|August 24, 2022
Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational studyHongsheng Zhou, Qingsong Yin, Jie Jin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2023
Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsisJiaxin Li, Yuqi Chen, Rui Li, et al.
Leukemia & Lymphoma|May 3, 2022
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCLDeborah A Katz, Joan D Morris, Michael P Chu, et al.
The Journal of Infectious Diseases|March 15, 2026
Unnoticed Entry, Noticed Transmission: Epidemiological Insights into China's First clade Ib MPXV clusterXin Ye, Peng He, Baiyun Yu, et al.
American Journal of Hematology|February 6, 2024
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemiaElias Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, et al.
Pageof 33